Ezio Gheno

Prof. Dr. Ezio Gheno

Genoa University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in Platelets
Verified
Journal Article
Closed access
Ezio GhenoEzio Gheno
Ezio Gheno
Carlos Fernando MourãoCarlos Fernando Mourão
Carlos Fernando Mourão
RMRafael Coutinho Coutinho Machado
Rafael Coutinho Coutinho Machado
ELEmanuele Stellet Lourenço
Emanuele Stellet Lourenço
RMRichard J Miron
Richard J Miron
Mônica Diuana Calasans-MaiaMônica Diuana Calasans-Maia
Mônica Diuana Calasans-Maia
Guided bone regeneration (GBR) is a process that involves the regeneration of bone defects through the application of occlusive membranes that mechanically exclude the population of non-osteogenic cells from the surrounding soft tissue. Interestingly, platelet-rich fibrin (PRF) has previously been proposed as an autologous GBR membrane despite its short-term resorption period of 2–3 weeks. Recent clinical observations have demonstrated that, by heating a liquid platelet-poor plasma (PPP) layer and mixing the cell-rich buffy coat zone, the resorption properties of heated albumin gel with liquid-PRF (Alb-PRF) can be significantly improved. The aim of this study was to evaluate the inflammatory reaction, biocompatibility, and extended degradation properties of a new autologous Alb-PRF membrane in comparison to commonly utilized standard PRF after nude mice implantation, according to ISO 10993–6/2016. Two standard preparations of PRF (L-PRF and H-PRF) were compared to novel Alb-PRF following subcutaneous implantation at 7, 14, and 21 days. All groups demonstrated excellent biocompatibility owing to their autologous sources. However, it is worth noting that, while both L-PRF and H-PRF membranes demonstrated significant or complete resorption by 21 days, the Alb-PRF membrane remained volume-stable throughout the duration of the study. This study demonstrates—for the first time, to the best of our knowledge—a marked improvement in the membrane stability of Alb-PRF. This indicates its future potential for use as a biological barrier membrane for GBR procedures with a long-lasting half-life, or as a biological filler material in esthetic medicine applications. Thus, further studies are warranted to explore future clinical applications in various fields of medicine.

1 January 2018 in International Journal of Growth Factors and Stem Cells in Dentistry
Verified
Journal Article
Closed access
CMCarlosFernando de Almeida Barros Mourão
CarlosFernando de Almeida Barros Mourão
Ezio GhenoEzio Gheno
Ezio Gheno
ELEmanuelleStellet Lourenço
EmanuelleStellet Lourenço
RBRenatade Lima Barbosa
Renatade Lima Barbosa
GKGregoriM Kurtzman
GregoriM Kurtzman
GAGutembergGomes Alves
GutembergGomes Alves
Background: One of the main issues pertaining to the use of fibrin membranes today, is their clinical efficacy for guided bone regeneration. This requires the need for membrane stability and a controlled resorption that enables the barrier to remain functionally during a relevant clinical time span. Human serum albumin is known to have an impact in the formation and stability of the fibrin networks density and permeability. Therefore, its interaction with fibrin aggregates may provide interesting features to autologous blood-derived biomaterials. Aim: In this context, the present study sought to characterize membranes produced through a modified protocol for concentrated growth factors (CGF) associated with activated plasma albumin gel (APAG). Method: Mixing denaturized albumin with CGF from the same blood samples into glass containers resulted in solid malleable membranes, with a modified denser ultrastructure as revealed by scanning electron microscopy (SEM). Results: The membranes presented a high density of nucleated cells, uniformly distributed along its length, and were able to release growth factors such as PDGF, VEGF, and FGF2 for 7 days. Conclusion: This preliminary study indicates that the protocol may provide autologous moldable and stable biomaterials for use as a soft tissue barrier, offering the basis for further research on its effectiveness for guided tissue regeneration.

1 November 2018 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
VBVeronica Bonazza
Veronica Bonazza
CHChristopher Dds Hajistilly
Christopher Dds Hajistilly
DPDinker Dds Patel
Dinker Dds Patel
JPJatan Dds Patel
Jatan Dds Patel
RWRita Dds Woo
Rita Dds Woo
Luigi Fabrizio RodellaLuigi Fabrizio Rodella
Luigi Fabrizio Rodella
Background: Platelet concentrates represent a new approach to improve tissue regeneration and can be used alone or together with autogenous bone, recombinant human growth factors, and/or other biomaterials, to enhance tissue regeneration. Among platelet concentrates, concentrated growth factors (CGFs) exhibit an interesting clinical and biotechnological application potential.Objective: The aim of this study was to evaluate the in vitro release of 4 growth factors (bone morphogenetic proteins [BMP] -2, BMP-7, transforming growth factor [TGF] -β1, and insulin-like growth factor [IGF] -1) by the enzyme-linked immunosorbent assay (ELISA) technique, in CGFs mixed or not with β-tricalcium phosphate (β-TCP), using or not the Round-up device, at different times.Methods: CGFs were obtained from healthy volunteers, mixed or not with β-TCP, using or not the Round-up device. The release of 4 growth factors from these CGFs was then measured at 5 hours, 1, 3, 6, and 8 days, using the ELISA assay.Results: Comparison of the results obtained with those achieved for CGFs alone showed that BMP2 and BMP-7 release, significantly increased in CGFs mixed with Round-up and β-TCP, TGF-β1 release was similar to CGFs alone, whereas IG-1 release was lower compared with CGFs alone.Conclusion: The present data suggest that β-TCP addition to CGF could enhance and improve tissue regeneration, especially bone regeneration, increasing the release of some growth factors that play an important role in osteogenesis.

16 February 2022 in Materials
Verified
Journal Article
Open access
PDF file
Ezio GhenoEzio Gheno
Ezio Gheno
GAGutemberg Alves
Gutemberg Alves
RGRoberto Ghiretti
Roberto Ghiretti
RMRafael Coutinho Coutinho Machado
Rafael Coutinho Coutinho Machado
Antonio SignoreAntonio Signore
Antonio Signore
Mônica Diuana Calasans-MaiaMônica Diuana Calasans-Maia
Mônica Diuana Calasans-Maia
Sticky bone, a growth factor-enriched bone graft matrix, is a promising autologous material for bone tissue regeneration. However, its production is strongly dependent on manual handling steps. In this sense, a new device was developed to simplify the confection of the sticky bone, named Sticky Bone Preparation Device (SBPD®). The purpose of this pilot study was to investigate the suitability of the SBPD® to prepare biomaterials for bone regeneration with autologous platelet concentrates. The SBPD® allows the blending of particulate samples from synthetic, xenograft, or autogenous bone with autologous platelet concentrates, making it easy to use and avoiding the need of further manipulations for the combination of the materials. The protocol for the preparation of sticky bone samples using the SBPD® is described, and the resulting product is compared with hand-mixed SB preparations regarding in vitro parameters such as cell content and the ability to release growth factors and cytokines relevant to tissue regeneration. The entrapped cell content was estimated, and the ability to release biological mediators was assessed after 7 days of incubation in culture medium. Both preparations increased the leukocyte and platelet concentrations compared to whole-blood samples (p < 0.05), without significant differences between SB and SBPD®. SBPD® samples released several growth factors, including VEGF, FGFb, and PDGF, at concentrations physiologically equivalent to those released by SB preparations. Therefore, the use of SBPD® results in a similar product to the standard protocol, but with more straightforward and shorter preparation times and less manipulation. These preliminary results suggest this device as a suitable alternative for combining bone substitute materials with platelet concentrates for bone tissue regeneration.

1 March 2020 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
GGGiuseppe Greco
Giuseppe Greco
SPSimone Di Piazza
Simone Di Piazza
JCJiemei Chan
Jiemei Chan
MZMirca Zotti
Mirca Zotti
Reem HannaReem Hanna
Reem Hanna
Andrea AmaroliAndrea Amaroli
Andrea Amaroli

14 August 2025 in Materials
Verified
Journal Article
Open access
PDF file
Larissa Azeredo da Silva Lessa NicolauLarissa Azeredo da Silva Lessa Nicolau
Larissa Azeredo da Silva Lessa Nicolau
SSSuelen Sartoretto
Suelen Sartoretto
PNPamella Nunes
Pamella Nunes
Ezio GhenoEzio Gheno
Ezio Gheno
JGJose M. Granjeiro
Jose M. Granjeiro
RLRAFAEL LOURO
RAFAEL LOURO
The different macro and micro geometries of dental implants are parameters that directly affect osseointegration, making them an important area for research. The objective of this preclinical study was to compare, through histological and histomorphometric analyses, the biological response of two different dental implant surfaces in osseointegration. Surface morphology and chemistry were characterized by SEM/EDX, optical-emission spectroscopy, protein adsorption (BSA), and adipose-derived stem-cell morphology. For the in vivo arm, ten commercially pure titanium implants (n = 5 LS160 + 5 SBAE) were placed bilaterally in the tibiae of five skeletally mature New Zealand rabbits (one implant of each surface per animal). After six weeks, undecalcified sections were prepared and bone-to-implant contact (BIC) and bone-area-fraction occupancy (BAFO) were quantified histomorphometrically. Data normality was confirmed with the Shapiro–Wilk test; paired two-tailed Student’s t-tests were applied (α = 0.05). Results: The descriptive histological analysis showed a fraction of pre-existing bone in all experimental groups, which probably ensured primary stability. Adjacent to this area, it was possible to observe peri-implant newformed bone in all tested groups. The results of the histomorphometric analysis of BIC and BAFO were considered normal by the Shapiro–Wilk test (p > 0.05); after six weeks of implantation, the BIC values for the LS160 and SBAE groups were 44.13 (15.83–72.43) and 39.24 (10.72–89.21), respectively. The analysis of variance (ANOVA and Tukey’s post-test) showed no statistical differences between the groups tested. Likewise, the bone volume density showed no statistical differences between the groups (ANOVA and Tukey’s post-test) with averages of 41.27 (C.I. 24.00–58.55) and 26.52 (C.I. −17.51–70.54) in the LS160 and SBAE groups, respectively. Although both surfaces showed similar osseointegration after six weeks, the new surface appears to be a promising, eco-friendly alternative to SBAE. Future studies with shorter time points and larger samples are needed to assess early biological responses.